Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus


Creative Commons License

Tuncel O. K. , AKYOL D. , PULLUKÇU H. , YAMAZHAN T. , Tasbakan M. , Sertoz O. O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.25, no.1, pp.25-31, 2019 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.4274/vhd.galenos.2019.0006
  • Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Page Numbers: pp.25-31

Abstract

Objectives: Data about the psychosocial side effects of direct-acting antiviral agents (DAA) used for the treatment of hepatitis C virus (HCV) infection is scarce. In this study, it is aimed to assess the psychiatric and sexual effects of ledipasvir/sofosbuvir (L/S) combination and paritaprevir-ritonavir-ombitasvir-dasabuvir (PROD) combination in patients with HCV infection.